Imaging BiometricsIQAIF OCF Yield % is 4.34 as of Jul. 01, 2026. The stock has 3 warning signs investors should review. Among 684 Healthcare Providers & Services companies, Imaging Biometrics ranks worse than 54.82% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Imaging Biometrics OCF Yield % Related Terms
Imaging Biometrics OCF Yield % Historical Data
* Premium members only.
The historical data trend for Imaging Biometrics's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Imaging Biometrics's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Imaging Biometrics OCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Imaging Biometrics's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Imaging Biometrics's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Imaging Biometrics (IQAIF) has a OCF Yield % of 4.34 as of Jul. 01, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Imaging Biometrics and its competitors. According to the industry distribution chart, Imaging Biometrics ranks #375 out of 684 companies in the Healthcare Providers & Services industry, placing it in the top 54.8%.
Is Imaging Biometrics' OCF Yield % too high?
Imaging Biometrics' current OCF Yield % is 4.34. The Healthcare Providers & Services industry median OCF Yield % is 5.50. Imaging Biometrics' value of 4.34 is 21.1% below this industry median. Based on the distribution chart, Imaging Biometrics ranks #375 out of 684 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does Imaging Biometrics' OCF Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Imaging Biometrics ranks #375 out of 684 companies for OCF Yield %. This places Imaging Biometrics in the lower half of its industry. The industry median OCF Yield % is 5.50. Imaging Biometrics' value of 4.34 is 21.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Healthcare Providers & Services company?
The median OCF Yield % among Healthcare Providers & Services companies is 5.50, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Imaging Biometrics's current OCF Yield % of 4.34 is 21.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Imaging Biometrics and its competitors. For the Healthcare Providers & Services industry, the median OCF Yield % is 5.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Imaging Biometrics's current OCF Yield % is 4.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imaging Biometrics stock overvalued right now?
Imaging Biometrics (IQAIF) has a current OCF Yield % of 4.34. The stock's GF Value™ is $0.03, compared to a current price of $0.02 — trading 33.3% below its estimated fair value. The current OCF Yield % is 4.34 and 21.1% below the Healthcare Providers & Services industry median of 5.50. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Imaging Biometrics (IQAIF), the current OCF Yield % is 4.34 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Imaging Biometrics Ltd formerly, IQ-AI Ltd operates as an investment company. The principal activity of the group is the provision of convenient, cost-effective, and clinical treatments to patients in the field of medical imaging diagnostics, based on technologies. Its geographical segment includes United Kingdom, Switzerland, European Union, and the United States of America and reportable segments are holding company expenses, medical software, Oral GaM and organ-on-a-chip. The company derives a majority of its revenue from the United States of America. It also supplies medical technology solutions and has a neuroimaging product portfolio.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IQAIF has been successfully added to your 